As a consequence of the wide range of available treatments that target the Human epidermal growth factor receptor 2 (HER2), identifying either HER2 expression or ERBB2 gene amplification in tumor tissue is of great impact for the management of breast cancer patients [1,2]. Here, ERBB2 is linked to neoplasm.